Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

@article{Barbara2009AminosalicylatesAO,
  title={Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome},
  author={G. Barbara and V. Stanghellini and C. Cremon and R. De Giorgio and L. Fronzoni and M. Serra and R. Corinaldesi},
  journal={Digestive Diseases},
  year={2009},
  volume={27},
  pages={115 - 121}
}
Growing evidence suggests that gastrointestinal immune activation may affect intestinal function and sensory perception, which contribute to symptom generation in patients with irritable bowel syndrome (IBS). The identification of higher counts of immunocytes (e.g. T cells and mast cells), mucosal and systemic immune activation, and increased mucosal permeability in patients with IBS has stimulated interest in the potential development of therapeutic approaches aimed at targeting the immune… Expand
The Immune System in Irritable Bowel Syndrome
Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
Inflammation in irritable bowel syndrome: Myth or new treatment target?
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
The Overlap in the Genetic Pathogenesis of Ulcerative Colitis and Irritable Bowel Syndrome
  • T. Kamiya
  • Medicine
  • Digestive Diseases and Sciences
  • 2013
...
1
2
3
...

References

SHOWING 1-10 OF 75 REFERENCES
Probiotics and Irritable Bowel Syndrome: Rationale and Clinical Evidence for Their Use
Role for protease activity in visceral pain in irritable bowel syndrome.
Postinfectious irritable bowel syndrome.
Increased mast cells in the irritable bowel syndrome
  • O’Sullivan, Clayton, +4 authors O’morain
  • Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2000
...
1
2
3
4
5
...